A newly published study showed that patients with relapsing multiple sclerosis (RMS) who started ocrelizumab (Ocrevus; ...

Clene has filed an NDA seeking accelerated approval of CNM-Au8 for ALS, following 2 missed primary trial endpoints and years ...

The NeurologyLive ® Editorial Advisory Board consists of physicians, clinicians, and researchers across the breadth of neurology who help to define the trends and drive the conversations in their ...

A four-year-old with regression, ptosis, and feeding problems illustrates the textbook features of severe early-onset TK2D ...

This week on NeurologyLive, there are a number of hot topics that we will be post ...

Intravenousocrelizumab (Ocrevus; Genentech) demonstrated noninferiority to oral fingolimod (Gilenya; Novartis) for ...

Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions ...

A quick-read roundup of 10 late-breaking abstracts from the 2026 MDS Congress, from phase 3 Parkinson disease readouts to long-term data in Huntington disease and Tourette syndrome, with the key ...

Welcome to NeurologyLive® 's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive 's widespread coverage in ...

This episode, "Follow-Up Care and the Caregiver's Role in Managing Agitation," features the panel closing the series with a ...

Pivotal AFFINITY DUCHENNE results showed microdystrophin expression above the prespecified threshold in 93% of evaluable ...